Unicycive Therapeutics, Inc. (UNCY)
5.32
-0.31
(-5.51%)
USD |
NASDAQ |
Aug 24, 16:00
5.35
+0.03
(+0.56%)
After-Hours: 20:00
Unicycive Therapeutics Debt to Equity Ratio : 0.0139 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0139 |
| March 31, 2026 | 0.025 |
| December 31, 2025 | 0.0066 |
| September 30, 2025 | 0.0135 |
| June 30, 2025 | 0.0249 |
| March 31, 2025 | 0.0486 |
| December 31, 2024 | 0.104 |
| September 30, 2024 | 0.029 |
| June 30, 2024 | -3.154 |
| March 31, 2024 | -1.918 |
| December 31, 2023 | -0.2129 |
| September 30, 2023 | 0.2962 |
| June 30, 2023 | -1.401 |
| March 31, 2023 | -1.763 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3326 |
| September 30, 2022 | 0.0419 |
| June 30, 2022 | 0.0234 |
| March 31, 2022 | 0.0203 |
| December 31, 2021 | 0.0186 |
| September 30, 2021 | 0.0054 |
| June 30, 2021 | -0.9757 |
| March 31, 2021 | -1.024 |
| December 31, 2020 | -0.9412 |
| September 30, 2020 | -0.9527 |
| June 30, 2020 | -0.5848 |
| March 31, 2020 | |
| December 31, 2019 | -0.5204 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Theriva Biologics, Inc. | 0.2915 |
| AbbVie, Inc. | -11.93 |
| Decoy Therapeutics, Inc. | 0.00 |
| Nkarta, Inc. | 0.2968 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 72.03M |
| Total Liabilities (Quarterly) | 18.76M |
| Shareholders Equity (Quarterly) | 53.27M |
| Current Ratio | 3.813 |
| Net Debt Paydown Yield | -0.03% |